Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Scott Mason

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Nature Communications|June 14, 2024
Ligand-based design of [<sup>18</sup>F]OXD-2314 for PET imaging in non-Alzheimer's disease tauopathiesAnton Lindberg, Emily Murrell, Junchao Tong, et al.
Synapse (New York, N.Y.)|February 17, 2009
Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallyprideRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 3, 2015
Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differencesMarc D Normandin, Ming-Qiang Zheng, Kuo-Shyan Lin, et al.
BJR Case Reports|December 10, 2020
First report of <sup>68</sup>Ga-PRGD2 PET/MRI molecular imaging of vaso-occlusion in a patient with sickle cell diseaseEnrico M Novelli, Chan Hong Moon, Tiffany A Pham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal dataMark E Schmidt, Ping Chiao, Gregory Klein, et al.
ACS Chemical Neuroscience|January 26, 2021
Radiosynthesis, <i>In Vitro</i> and <i>In Vivo</i> Evaluation of [<sup>18</sup>F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-TauopathiesAnton Lindberg, Ashley C Knight, Daniel Sohn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2012
The future of USP monographs for PET drugsSally Schwarz, Jeffrey Norenberg, Marc Berridge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 2021
What Is T+? A Gordian Knot of Tracers, Thresholds, and TopographiesVictor L Villemagne, Brian J Lopresti, Vincent Doré, et al.
Journal of Neurochemistry|June 9, 2007
A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activationSriram Venneti, Brian J Lopresti, Guoji Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2021
Direct Comparison of the Tau PET Tracers <sup>18</sup>F-Flortaucipir and <sup>18</sup>F-MK-6240 in Human SubjectsAlexandra Gogola, Davneet S Minhas, Victor L Villemagne, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Nature Communications|June 14, 2024
Ligand-based design of [<sup>18</sup>F]OXD-2314 for PET imaging in non-Alzheimer's disease tauopathiesAnton Lindberg, Emily Murrell, Junchao Tong, et al.
Synapse (New York, N.Y.)|February 17, 2009
Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallyprideRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 3, 2015
Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differencesMarc D Normandin, Ming-Qiang Zheng, Kuo-Shyan Lin, et al.
BJR Case Reports|December 10, 2020
First report of <sup>68</sup>Ga-PRGD2 PET/MRI molecular imaging of vaso-occlusion in a patient with sickle cell diseaseEnrico M Novelli, Chan Hong Moon, Tiffany A Pham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal dataMark E Schmidt, Ping Chiao, Gregory Klein, et al.
ACS Chemical Neuroscience|January 26, 2021
Radiosynthesis, <i>In Vitro</i> and <i>In Vivo</i> Evaluation of [<sup>18</sup>F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-TauopathiesAnton Lindberg, Ashley C Knight, Daniel Sohn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2012
The future of USP monographs for PET drugsSally Schwarz, Jeffrey Norenberg, Marc Berridge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 2021
What Is T+? A Gordian Knot of Tracers, Thresholds, and TopographiesVictor L Villemagne, Brian J Lopresti, Vincent Doré, et al.
Journal of Neurochemistry|June 9, 2007
A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activationSriram Venneti, Brian J Lopresti, Guoji Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2021
Direct Comparison of the Tau PET Tracers <sup>18</sup>F-Flortaucipir and <sup>18</sup>F-MK-6240 in Human SubjectsAlexandra Gogola, Davneet S Minhas, Victor L Villemagne, et al.
Pageof 5